| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Third Harmonic Bio, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 136K | Mar 6, 2023 | Direct | ||
| Neoleukin Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 70K | Feb 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| THRD | Third Harmonic Bio, Inc. | Mar 6, 2023 | 5 | $0 | 4 | Mar 8, 2023 | Chief Financial Officer |
| THRD | Third Harmonic Bio, Inc. | Oct 25, 2022 | 1 | $0 | 4 | Oct 27, 2022 | Chief Financial Officer |
| THRD | Third Harmonic Bio, Inc. | Sep 14, 2022 | 0 | $0 | 3 | Sep 14, 2022 | Chief Financial Officer |
| NLTX | Neoleukin Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Financial Officer |
| NLTX | Neoleukin Therapeutics, Inc. | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Chief Financial Officer |